Study shows Enhanced Recovery After Surgery lowers pain and opioid use for lung cancer patients
MD Anderson surgeons have found a way to reduce pain and opioid use for lung cancer patients undergoing a lung resection. A recent study led by David Rice, M.B. BCh, professor of Thoracic and Cardiovascular Surgery, and published in the Annals of Surgery, showed that using an Enhanced Recovery After Surgery (ERAS) pathway employing a long-acting local anesthetic (liposomal bupivacaine)...
Acute myeloid leukemia’s minimal residual disease targeted by Moon Shot
In patients with leukemia, complete remission after treatment is currently defined by the absence of cancer cells in a bone marrow biopsy...
ECLIPSE looks to extinguish leukemia by uncovering new treatment targets
MD Anderson has created a new research platform to drive the discovery of new therapeutic agents for patients with leukemia by investigating...
Combination chemotherapy before blood stem cell transplant improves progression-free survival
A randomized Phase III clinical trial combining two common chemotherapy agents as a pre-stem cell transplant treatment at The University of Texas MD Anderson Cancer Center demonstrated significantly increased progression-free survival in multiple myeloma patients.
The study, which followed 202 patients, compared busulfan with melphalan versus melphalan alone. Progression-free survival was 65 months for patients receiving combination...
MD Anderson company to develop cell therapies for cancer
Cell-based immunotherapies such as chimeric antigen receptors (CAR T), T-cell receptor (TCR) engineered T cells, tumor-infiltrating lymphocytes...
How to handle side effects of CAR-T cell therapy
Immune-cell based therapies opening a new frontier for cancer treatment carry unique, potentially lethal side effects that provide a new challenge...
Utilizing the body’s natural born killers to take out blood cancers
Natural killer cells sound menacing, but they play a friendly role in keeping us healthy. And they might do much more in stopping...
Drug outperforms chemo for treatment of acute lymphoblastic leukemia
The biopharmaceutical drug blinatumomab is more effective for the treatment of relapsed or treatment-resistant acute lymphoblastic leukemia...
New partnerships push innovative approaches to cancer treatment forward
In the modern world of biomedical research, collaborations between academic institutions and pharmaceutical and biotech companies have become...
After a stem cell transplant, professor returns to the classroom
Chemistry professor Bindu Chakravarty rarely missed a day teaching at Houston Community College. So when she called in sick one morning, it...